A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trialZoltan Vajo
University of Debrecen, Medical and Health Sciences Center, Debrecen, Hungary
Clin Vaccine Immunol 19:313-8. 2012
..All adverse events were rare, mild, and transient. We found that the present reduced-dose vaccine is safe and immunogenic in healthy adult and elderly subjects and triggers immune responses that comply with licensing criteria...
- Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children
Zoltan Vajo
National Center for Immunology and Allergy, State Health Center, Martonhegyi ut 6, Budapest, Hungary
Pediatr Infect Dis J 27:1052-6. 2008
..Children may be particularly vulnerable to the pandemic virus, and they may react differently than adults to vaccines. We report the results of the first clinical trial of an H5N1 vaccine in children...
- The seasonal influenza vaccine Agriflu(®)
Zoltan Vajo
University of Debrecen, Medical and Health Sciences Center, Debrecen, Hungary
Expert Rev Vaccines 10:1513-7. 2011
....
- Influenza A (H5N1) pandemic prototype vaccine Fluval
Zoltan Vajo
University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
Expert Rev Vaccines 8:619-24. 2009
....
- Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial
Zoltan Vajo
University of Debrecen, Medical and Health Sciences Centre, Debrecen, Hungary
Lancet 375:49-55. 2010
..We investigated the safety and immunogenicity of a whole-virion, inactivated, adjuvanted pandemic H1N1 vaccine in adult and elderly volunteers, given without or simultaneously with the 2009-10 seasonal trivalent influenza vaccine...
- A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development
Zoltan Vajo
University of Debrecen, Debrecen, Hungary
J Virol 84:1237-42. 2010
....
- Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?
Zoltan Vajo
National Center for Allergy and Immunology, Budapest, Hungary
Influenza Other Respi Viruses 2:221-8. 2008
..Here we report the results of the yearly licensing studies of the past 11 influenza seasons (1997-2007) with a trivalent, inactivated whole virus vaccine with an aluminum phosphate adjuvant system...
- Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to
Gyorgy Fazekas
Omninvest Ltd, Pilisborosjeno, Budapest, Hungary
Clin Vaccine Immunol 16:437-43. 2009
..Our findings highlight the importance of stockpiling, since cross-immune reactions induced by prepandemic vaccines will likely reduce morbidity and mortality in case of a pandemic...
- Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study
Zoltan Vajo
University of Debrecen Medical Center, Debrecen, Hungary
Wien Klin Wochenschr 121:202-8. 2009
....
- Echocardiographic findings in patients with Williams-Beuren syndrome
Dora Scheiber
Semmelweis Medical School, Budapest, Hungary
Wien Klin Wochenschr 118:538-42. 2006
..These results could contribute to the refinement of diagnostic criteria and recommendations for cardiovascular follow-up of patients with this syndrome...
